DarioHealth
DRIO
58 hedge funds and large institutions have $162M invested in DarioHealth in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 20 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
64% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 11
56% more capital invested
Capital invested by funds: $103M → $162M (+$58.1M)
20% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 20
7% more funds holding
Funds holding: 54 → 58 (+4)
0.64% more ownership
Funds ownership: 1.79% → 2.43% (+0.64%)
3% less call options, than puts
Call options by funds: $1.65M | Put options by funds: $1.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14M |
| 2 |
CHM
Collaborative Holdings Management
New York
|
+$9.68M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$6.61M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$5.96M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$6.86M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.44M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$2.61M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.14M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.13M |
DRIO Hedge Fund Activity: Q2 2021 in Review
58 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2021, worth a combined $162M — up 56% from $103M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new DRIO positions and 20 closed out — a net gain of 4 holders — while 18 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, adding an estimated $14M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $6.86M sold.
- 58 institutional investors held DarioHealth (DRIO) as of Q2 2021, up from 54 in Q1 2021.
- Funds reported $162M of DarioHealth stock for Q2 2021, up 56% quarter-over-quarter.
- 24 funds opened new DarioHealth positions in Q2 2021 and 20 closed out, a net change of +4 holders.
- The largest DarioHealth buyer in Q2 2021 was BlackRock, an estimated $14M added.
- The largest DarioHealth seller in Q2 2021 was Pura Vida Investments, an estimated $6.86M sold.
Based on aggregated 13F filings for Q2 2021.